AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in AIM ImmunoTech Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −2 vs. Q1 2023
- Shares held
- 4.49M
- −273.1K (−5.7%) vs. Q1 2023
- Total value
- $3.01M
- +$959.0K (+46.8%) vs. Q1 2023
- New holders
- 5
- 6 more added
- Sold out
- 7
- 4 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $325.6K |
| Q1 2026 | 18 | $102.8K |
| Q4 2025 | 13 | $119.8K |
| Q3 2025 | 15 | $293.9K |
| Q2 2025 | 12 | $104.8K |
| Q1 2025 | 34 | $590.0K |
| Q4 2024 | 35 | $919.3K |
| Q3 2024 | 33 | $2.43M |
| Q2 2024 | 36 | $3.15M |
| Q1 2024 | 33 | $1.93M |
| Q4 2023 | 38 | $1.83M |
| Q3 2023 | 38 | $1.97M |
| Q2 2023 | 34 | $3.01M |
| Q1 2023 | 36 | $2.05M |
| Q4 2022 | 39 | $1.67M |
| Q3 2022 | 38 | $3.36M |
| Q2 2022 | 40 | $4.68M |
| Q1 2022 | 38 | $7.12M |
| Q4 2021 | 43 | $6.86M |
| Q3 2021 | 38 | $14.7M |
| Q2 2021 | 39 | $15.5M |
| Q1 2021 | 38 | $16.8M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding AIM ImmunoTech Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,988,704 | $1.33M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 707,544 | $474.1K | 0.00% | −109,583−13.4% | Reduced |
| Morgan Stanley | 435,558 | $291.8K | 0.00% | −175,019−28.7% | Reduced |
| Geode Capital Management, LLC | 380,905 | $255.2K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 178,808 | $120.0K | 0.00% | +10,100+6.0% | Added |
| State Street Corp | 173,103 | $116.0K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 140,000 | $93.8K | 0.00% | −4,000−2.8% | Reduced |
| Bridgeway Capital Management, LLC | 108,900 | $73.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 86,517 | $58.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 54,613 | $36.6K | 0.00% | +44,601+445.5% | Added |
| DRW Securities, LLC | 37,000 | $25.0K | 0.00% | +37,000 | New |
| SeaCrest Wealth Management, LLC | 37,063 | $24.8K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 25,268 | $16.9K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 22,144 | $14.8K | 0.00% | +22,144 | New |
| Captrust Financial Advisors | 20,000 | $13.4K | 0.00% | 00.0% | Unchanged |
| ForthRight Wealth Management, LLC | 20,000 | $13.4K | 0.01% | 00.0% | Unchanged |
| Community Bank, N.A. | 13,226 | $8.86K | 0.00% | 00.0% | Unchanged |
| D.B. Root & Company, LLC | 12,050 | $8.07K | 0.00% | +12,050 | New |
| Traynor Capital Management, Inc. | 11,777 | $7.89K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 10,299 | $6.90K | 0.00% | −6,311−38.0% | Reduced |
| SNS Financial Group, LLC | 10,000 | $6.70K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 5,001 | $3.35K | 0.00% | +5,000+500,000.0% | Added |
| Tower Research Capital LLC (TRC) | 4,785 | $3.21K | 0.00% | +2,926+157.4% | Added |
| Advisor Group Holdings, Inc. | 2,276 | $1.52K | 0.00% | 00.0% | Unchanged |
| Hoey Investments, Inc | 1,000 | $670 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 749 | $502 | 0.00% | +17+2.3% | Added |
| Proequities, Inc. | 500 | $335 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 170 | $150 | 0.00% | 00.0% | Unchanged |
| Huntington National Bank | 57 | $38 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 13 | $9 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3 | $2 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 1 | $1 | 0.00% | +1 | New |
| Royal Bank of Canada | 308 | $0 | 0.00% | +298+2,980.0% | Added |
| CWM, LLC | 1 | $0 | 0.00% | +1 | New |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −29,924−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −20,300−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −20,340−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Creative Capital Management Investments LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| New Millennium Group LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |